Image
29.07.2022
The Diabetes Football Community
As the UEFA Women’s Euro competition continues to heat up, with the Lionesses due to face Germany in the ...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more